Press Releases from MetrioPharm AG (2 total)
MetrioPharm Achieves 50% of Target Patients Randomized in MP1032 Phase II Clinic …
Zurich, August 14, 2018. MetrioPharm AG, a pharmaceutical biotech company developing drugs for chronic inflammatory diseases, today announced that more than 50% of patients with…
MetrioPharm announces first patients dosed in a clinical phase IIa trial for MP1 …
Zurich, June 07, 2016. MetrioPharm AG announces the first dosing of patients in the phase IIa clinical trial MP1032-CT02 on May 24, 2016. To date,…
Go To Page:
